Literature DB >> 32471670

Pathophysiology of Contrast-Induced Acute Kidney Injury.

Shweta Bansal1, Rahul N Patel2.   

Abstract

Passing contrast media through the renal vascular bed leads to vasoconstriction. The perfusion decrease leads to ischemia of tubular cells. Through ischemia and direct toxicity to renal tubular cells, reactive oxygen species formation is increased, enhancing the effect of vasoconstrictive mediators and decreasing the bioavailability of vasodilative mediators. Reactive oxygen species formation leads to oxidative damage to tubular cells. These interacting pathways lead to tubular necrosis. In the pathophysiology of contrast-induced acute kidney injury, low osmolar and iso-osmolar agents have theoretic advantages and disadvantages; however, clinically the difference in incidence of contrast-induced acute kidney injury has not changed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast media adverse effects; Contrast media toxicity; Contrast-associated acute kidney injury; Contrast-induced acute kidney injury; Contrast-induced nephropathy

Mesh:

Substances:

Year:  2020        PMID: 32471670     DOI: 10.1016/j.iccl.2020.03.001

Source DB:  PubMed          Journal:  Interv Cardiol Clin        ISSN: 2211-7458


  3 in total

1.  Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial.

Authors:  Guang Ma; Min Li; Wei Teng; Zhaohui He; Xiaojv Zhai; Zhenhua Xia
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

Review 2.  An Update of Long-Noncoding RNAs in Acute Kidney Injury.

Authors:  Lina Yang; Bo Wang; Liang Ma; Ping Fu
Journal:  Front Physiol       Date:  2022-03-08       Impact factor: 4.566

3.  Incidence and Risk Factors of Contrast-Induced Acute Kidney Injury in Sudanese Patients Undergoing Coronary Angiography: A Descriptive Prospective Study.

Authors:  Mohira A Abdalla; Kannan O Ahmed; Bashir A Yousef
Journal:  Cureus       Date:  2022-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.